Bispecific therapies require clearer terminology to improve safety and communication.
Tahsin Imam, PharmD
Advertisement
Articles by Tahsin Imam, PharmD
Advertisement
Latest Updated Articles
The Term 'Bispecific Antibody' Is No Longer EnoughPublished: June 16th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
Improved Outcomes in NDTE Multiple Myeloma With Belantamab Mafodotin Plus VRd Following 2 Years of Maintenance
2
FDA Approves Guselkumab for Pediatric Plaque Psoriasis, Psoriatic Arthritis
3
FDA Approves 10% IVIG Formulation For Adults With Primary Humoral Immunodeficiency
4
Annual Pharmacy Technician Convention Brings Educational Opportunities, Leadership Development
5
